335 related articles for article (PubMed ID: 24736024)
21. The effect of statins on risk and survival of gynecological malignancies.
Lavie O; Pinchev M; Rennert HS; Segev Y; Rennert G
Gynecol Oncol; 2013 Sep; 130(3):615-9. PubMed ID: 23718932
[TBL] [Abstract][Full Text] [Related]
22. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.
Siristatidis C; Sergentanis TN; Kanavidis P; Trivella M; Sotiraki M; Mavromatis I; Psaltopoulou T; Skalkidou A; Petridou ET
Hum Reprod Update; 2013; 19(2):105-23. PubMed ID: 23255514
[TBL] [Abstract][Full Text] [Related]
23. Statin use and risk of Parkinson's disease: A meta-analysis.
Sheng Z; Jia X; Kang M
Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
[TBL] [Abstract][Full Text] [Related]
24. Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis.
Xie W; Ning L; Huang Y; Liu Y; Zhang W; Hu Y; Lang J; Yang J
Oncotarget; 2017 Jun; 8(25):41508-41517. PubMed ID: 28489569
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction.
Liu G; Zheng XX; Xu YL; Ru J; Hui RT; Huang XH
Am J Cardiol; 2014 Apr; 113(7):1198-204. PubMed ID: 24513478
[TBL] [Abstract][Full Text] [Related]
26. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Hall KL; Dewar MA; Perchalski J
Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
[TBL] [Abstract][Full Text] [Related]
27. Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology.
Viikki M; Pukkala E; Hakama M
Obstet Gynecol; 1998 Aug; 92(2):269-73. PubMed ID: 9699765
[TBL] [Abstract][Full Text] [Related]
28. Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
Michaan N; Gortzak-Uzan L; Grisario D; Laskov I
Int J Gynaecol Obstet; 2018 Aug; 142(2):176-181. PubMed ID: 29742279
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of the gynecologic cancers.
Cramer DW
Compr Ther; 1978 Mar; 4(3):9-17. PubMed ID: 630831
[No Abstract] [Full Text] [Related]
31. Clinical statistics of gynecologic cancers in Japan.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
[TBL] [Abstract][Full Text] [Related]
32. Statin use and female reproductive organ cancer risk in a large population-based setting.
Yu O; Boudreau DM; Buist DS; Miglioretti DL
Cancer Causes Control; 2009 Jul; 20(5):609-16. PubMed ID: 19043788
[TBL] [Abstract][Full Text] [Related]
33. Role of PET in gynecologic malignancy.
Grigsby PW
Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
[TBL] [Abstract][Full Text] [Related]
35. Physical activity and gynecologic cancer prevention.
Cust AE
Recent Results Cancer Res; 2011; 186():159-85. PubMed ID: 21113764
[TBL] [Abstract][Full Text] [Related]
36. Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database.
Kim DS; Ahn HS; Kim HJ
Int J Cancer; 2022 Apr; 150(7):1156-1165. PubMed ID: 34751444
[TBL] [Abstract][Full Text] [Related]
37. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.
Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ
Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711
[TBL] [Abstract][Full Text] [Related]
38. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
39. Statins and primary liver cancer: a meta-analysis of observational studies.
Pradelli D; Soranna D; Scotti L; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Eur J Cancer Prev; 2013 May; 22(3):229-34. PubMed ID: 23010949
[TBL] [Abstract][Full Text] [Related]
40. Impact of statins on risk of stroke: a meta-analysis.
Henyan NN; Riche DM; East HE; Gann PN
Ann Pharmacother; 2007 Dec; 41(12):1937-45. PubMed ID: 17986516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
